Long-term follow-up of KTP laser turbinate reduction for the treatment of obstructive rhinopathy | Ear, Nose & Throat Journal Skip to content Skip to navigation

Long-term follow-up of KTP laser turbinate reduction for the treatment of obstructive rhinopathy

| Reprints
April 30, 2017
by Hemal Raja, FRCS, ORL-HNS; Scott Mitchell, MBChB, MRCS, DOHNS; George Barrett, MRCS, DOHNS; Ashish Sharma, MBBS, MA, MRCS, MRCP; Derek W. Skinner, FRCS, ORL-HNS

Abstract

We investigated the subjective, long-term, patient-reported symptom control after endoscopic potassium titanyl phosphate (KTP) laser reduction of the inferior turbinates. Symptoms were listed preoperatively and patients were asked, via telephone interview, the status of their symptoms. Chi-square analysis was used to assess statistical significance of the surgical intervention. Thirty-six patients (male:female ratio: 5:4) aged 13 to 80 years (mean: 37.2) were available for follow-up. The mean follow-up time was 68.47 months (range: 44 to 92). The principal symptom patients experienced was nasal obstruction (94.4%); postoperative improvement in this symptom at 44 months and beyond was reported by 85.3% of patients (chi-square 16.94, p < 0.001). Other symptoms, such as rhinorrhea and sneezing, showed no significant improvement at long-term follow-up. This study adds evidence to the long-term improvements in obstructive nasal symptoms using KTP laser reduction of the turbinates.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

You may also like to: